These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 6454343
21. An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis. Maynor LM, Carl DE, Matzke GR, Gehr TW, Farthing C, Farthing D, Brophy DF. Pharmacotherapy; 2008 Aug; 28(8):977-83. PubMed ID: 18657014 [Abstract] [Full Text] [Related]
22. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics. Vuye A. Arzneimittelforschung; 1981 Aug; 31(8):1290-5. PubMed ID: 6457607 [Abstract] [Full Text] [Related]
23. Lack of interference of five new beta-lactam antibiotics with serum creatinine determination. LeBel M, Paone RP, Lewis GP. Drug Intell Clin Pharm; 1983 Dec; 17(12):908-10. PubMed ID: 6317326 [Abstract] [Full Text] [Related]
31. On the disulfiram-like activity of moxalactam. Elenbaas RM, Ryan JL, Robinson WA, Singsank MJ, Harvey MJ, Klaassen CD. Clin Pharmacol Ther; 1982 Sep; 32(3):347-55. PubMed ID: 6213349 [Abstract] [Full Text] [Related]
32. Effects of moxalactam on blood coagulation and platelet function. Bang NU, Tessler SS, Heidenreich RO, Marks CA, Mattler LE. Rev Infect Dis; 1982 Sep; 4 Suppl():S546-54. PubMed ID: 6218565 [Abstract] [Full Text] [Related]
33. New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime. Andrassy K, Koderisch J, Fritz S, Ritz E. Clin Ther; 1983 Sep; 6(1):34-42. PubMed ID: 6325005 [Abstract] [Full Text] [Related]
34. Interference of selected second- and third-generation cephalosporins with creatinine determination. Guay DR, Meatherall RC, Macaulay PA. Am J Hosp Pharm; 1983 Mar; 40(3):435-8. PubMed ID: 6846351 [Abstract] [Full Text] [Related]
38. Five cephalosporins: pharmacokinetics and their relation to antibacterial potency. Sohn C, Pitkin D, Grappel S, Zajac I, Actor P, Alexander F, Lentnek A, Wikler M, Stote R, Dubb J. Clin Ther; 1984 Mar; 6(4):560-70. PubMed ID: 6467282 [Abstract] [Full Text] [Related]
39. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction. Bolton WK, Scheld WM, Spyker DA, Overby TL, Sande MA. Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555 [Abstract] [Full Text] [Related]
40. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M, Kotaska K, Kukacka J, Vavrova V, Kuzelova M, Ticha J, Prusa R. J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]